Ionis Pharmaceuticals, Inc.
Modified CRISPR RNA and modified single CRISPR RNA and uses thereof

Abstract:

The present disclosure provides compounds comprising modified oligonucleotides for use in CRISPR. In certain embodiments, such modified oligonucleotides provide improved properties of crRNA. In certain embodiments, such modified oligonucleotides provide improved properties of scrRNA.